Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

COR Therapeutics' cardiovascular drug candidate enters phase I trials

Feb. 5, 1997

DuPont Merck reports new fibrinogen antagonists

Jan. 31, 1997

New anticoagulant drug candidates from Berlex

Jan. 31, 1997

Serine protease inhibitors reported by Akzo Nobel

Jan. 31, 1997

Dutch investigators find method of improving t-PA therapy

Jan. 30, 1997

Pivotal Integrilin study fully enrolled

Jan. 29, 1997

Thrombin inhibitors from BioChem Pharma

Jan. 28, 1997

Searle describes new platelet aggregation inhibitors

Jan. 28, 1997

Antithrombotics described by Terumo

Jan. 27, 1997

Sumitomo claims antiplatelet agents

Jan. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...